Selenium to Improve Neurological Outcome After Cardiac Arrest

NCT01390506 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped The company did not provide the study product

Conditions

Cardiac Arrest

Interventions

DRUG: Sodium-selenite
DRUG: Placebo

Sponsor

Medical University of Graz